These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 35768833)
21. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer. Wang Y; Xu Y; Zhang Y Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765 [TBL] [Abstract][Full Text] [Related]
22. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
23. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848 [TBL] [Abstract][Full Text] [Related]
24. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation. Xiang X; Guo Y; Chen Z; Zhang F; Huang J; Qin Y Medicine (Baltimore); 2022 Dec; 101(51):e32558. PubMed ID: 36595859 [TBL] [Abstract][Full Text] [Related]
25. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma. Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463 [TBL] [Abstract][Full Text] [Related]
26. Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics. Pan J; Zhang X; Fang X; Xin Z Front Genet; 2021; 12():739470. PubMed ID: 34497636 [TBL] [Abstract][Full Text] [Related]
27. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer. Lin Y; Gan F; He X; Deng H; Li Y J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656 [TBL] [Abstract][Full Text] [Related]
28. Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer. Chen W; Feng Z; Huang J; Fu P; Xiong J; Cao Y; Liu Y; Tu Y; Li Z; Jie Z; Xiao T Dis Markers; 2021; 2021():7724997. PubMed ID: 34394774 [TBL] [Abstract][Full Text] [Related]
29. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
30. Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer. Sun YF; Chen L; Xia QJ; Wang TH J Cancer Res Clin Oncol; 2023 Sep; 149(12):10217-10234. PubMed ID: 37269345 [TBL] [Abstract][Full Text] [Related]
31. Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. Fang C; Liu S; Feng K; Huang C; Zhang Y; Wang J; Lin H; Wang J; Zhong C Sci Rep; 2022 Apr; 12(1):6642. PubMed ID: 35459272 [TBL] [Abstract][Full Text] [Related]
32. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma. Liu JW; Supandi F; Dhillon SK Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853 [TBL] [Abstract][Full Text] [Related]
33. Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer. Wang J; Jiang Z; Wang K; Zheng Q; Jian J; Liu X; Chen Z; Yang R; Wang L Aging (Albany NY); 2024 Feb; 16(3):2812-2827. PubMed ID: 38319718 [TBL] [Abstract][Full Text] [Related]
34. Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer. Hao S; Yang Z; Wang G; Cai G; Qin Y BMC Cancer; 2024 Aug; 24(1):958. PubMed ID: 39107713 [TBL] [Abstract][Full Text] [Related]
35. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment. Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X Front Immunol; 2022; 13():903758. PubMed ID: 36016939 [TBL] [Abstract][Full Text] [Related]
36. Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma. Lai J; Miao S; Ran L Sci Rep; 2023 Feb; 13(1):2114. PubMed ID: 36747047 [TBL] [Abstract][Full Text] [Related]
37. Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma. Yao N; Zuo L; Yan X; Qian J; Sun J; Xu H; Zheng F; Efird JT; Kawagoe I; Wang Y; Ni S Transl Lung Cancer Res; 2022 Apr; 11(4):632-646. PubMed ID: 35529787 [TBL] [Abstract][Full Text] [Related]
38. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis. Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R Front Genet; 2022; 13():907331. PubMed ID: 35938001 [No Abstract] [Full Text] [Related]
39. The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer. Liu C; Gao Y; Ni J; Chen S; Hu Q; Wang C; Hu M; Chen M BMC Cancer; 2022 Jul; 22(1):788. PubMed ID: 35850679 [TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer. Geng H; Qian R; Zhang L; Yang C; Xia X; Wang C; Zhao G; Zhang Z; Zhu C Aging (Albany NY); 2022 Aug; 14(15):6358-6376. PubMed ID: 35969182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]